These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2976254)

  • 1. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH; Nielsen EB
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):315-8. PubMed ID: 2948372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
    Simonneaux V; Murrin LC; Ebadi M
    J Pharmacol Exp Ther; 1990 Apr; 253(1):214-20. PubMed ID: 2139469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).
    Madras BK; Fahey MA; Canfield DR; Spealman RD
    J Neurochem; 1988 Sep; 51(3):934-43. PubMed ID: 2970527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W; Neuscheler P; Nagel J; Müller CE
    Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ; Brassard DL; Sibley DR
    Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
    Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
    Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (-)-3-PPP.
    George SR; Watanabe M; Seeman P
    J Neural Transm; 1985; 64(1):13-33. PubMed ID: 2933489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivation of dopamine D1 and D2 receptors increases the affinity of cholecystokinin-8 receptors in membranes from post-mortem human caudate-putamen.
    von Euler G; Mailleux P; von Euler M; Schiffmann SN; Vanderhaeghen JJ; Fuxe K
    Brain Res; 1992 Jul; 584(1-2):157-62. PubMed ID: 1325243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.
    Pettibone DJ; Totaro JA; Clineschmidt BV
    J Neural Transm; 1987; 69(1-2):147-51. PubMed ID: 2953862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK; Penney JB; Young AB
    Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates.
    Duffy RA; Kaminska G; Chipkin RE; McQuade RD
    Pharmacol Biochem Behav; 1992 Jan; 41(1):235-8. PubMed ID: 1531704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
    J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.